India is 'no replacement' for China in pharmaceutical supply chain: Consultant

Sam Radwan from Enhance International says China's sheer dominance in APIs (active pharmaceutical ingredients) makes it crucial in producing even the most basic meds. He says China is irreplaceable in the global pharmaceutical and biotech market, and that tariffs will lead to inevitably higher healthcare costs.